Sandbox:Mitra3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | | | {{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | | | ||
|C01=<div style="float: left; text-align: left; width: 12em; padding:1em;"> '''Thrmobolytics''' <br> | |C01=<div style="float: left; text-align: left; width: 12em; padding:1em;"> '''Thrmobolytics''' <br> | ||
C01=<div style="float: left; text-align: left; width: 12em; padding:1em;"> '''PCI''' <br> | |||
|C02= • Avoidance of preload reducing agents, such as:<br> | |C02= • Avoidance of preload reducing agents, such as:<br> | ||
*Nitrates | *Nitrates | ||
Revision as of 17:51, 3 August 2020
| Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrmobolytics C01= PCI | • Avoidance of preload reducing agents, such as:
| • Systemic or pulmonary vasodilators: *Inhaled nitric oxide | • In patients with bradyarrhthmias: Atropine Pacemaker | In patients with refractory hypotension | May be needed in patients with cardiogenic shock secondary to RVMI | {{{ }}} | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||